Recombinant Zebrafish APELA
Cat.No. : | APELA-8464Z |
Product Overview : | Recombinant Zebrafish APELA full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
- Download
Source : | Mammalian Cells |
Species : | Zebrafish |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC. |
Storage Buffer : | PBS buffer |
Gene Name : | apela apelin receptor early endogenous ligand [ Danio rerio (zebrafish) ] |
Official Symbol : | APELA |
Gene ID : | 100536023 |
mRNA Refseq : | NM_001297547 |
Protein Refseq : | NP_001284476 |
UniProt ID : | P0DMC2 |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (20)
Ask a questionYes, large-scale production of APELA can be achieved through genetic engineering technology.
The recombinant APELA protein has been shown to have a protective effect against cardiovascular disease in animal studies, but more research support is needed in the preclinical stage.
More research is needed to confirm the effect of APELA on lung disease, but preliminary experimental results show some potential.
The duration of treatment varies depending on the type of disease and the individual patient, and generally the results can be seen in weeks to months.
APELA may have the potential to promote organ rehabilitation and reduce rejection after organ transplantation, but more studies are needed to verify its effect.
The recombinant APELA protein has potential clinical applications and could be used to treat diseases such as cardiovascular disease, organ transplantation, inflammation and tumors.
At present, it is still in the research stage, and no clinical trial results have been published for APELA .
APELA may have a certain effect on patients of different ages, and the therapeutic dose should be adjusted according to the specific situation in different ages.
The recombinant APELA protein shows some anti-inflammatory properties and may play a role in the treatment of some inflammatory diseases.
There are currently no commercial APELA products, but as research progresses, related products may be available in the future.
The recombinant APELA protein has the potential to be a personalised therapeutic agent, as its therapeutic effect may vary from patient to patient.
No significant side effects of APELA have been found, but individual patient differences and safety assessments should be considered when using APELA.
The specific pharmacokinetic characteristics need to be further studied to better guide clinical use.
Yes, APELA belongs to a group of proteins closely related to APELIN, and several similar s have been discovered.
Because the recombinant APELA protein is related to APELA produced by the body itself, the immune response is affected, but the risk of rejection is low.
Current studies have not found evidence that the recombinant APELA protein has a significant effect on the human endocrine system.
The specific production cost is related to the process, dosage and other factors, and further research and development are needed to reduce the production cost.
Studies have shown that recombinant APELA protein may play a role in promoting growth and invasion in some tumors, but the specific mechanism needs to be further studied.
The recombinant APELA protein has the ability to selectively bind to specific receptors and can therefore be considered as a targeted therapeutic approach.
Most of the current research is done by injection, but it is possible that in the future, a way to export the drug will be developed to improve the convenience of treatment.
Customer Reviews (3)
Write a reviewThe results of many experiments show that the production process and quality control are good.
APELA they produced is safe and can be used with confidence.
The stability is very strong, and the stability of its structure and function can be maintained even after a lot of use, which shows its excellent quality and reliability.
Ask a Question for All APELA Products
Required fields are marked with *
My Review for All APELA Products
Required fields are marked with *
Inquiry Basket